TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

Stock Information for TFF Pharmaceuticals Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.